Bioinformatics Analysis of the Prognostic Significance of VPS16 in Hepatocellular Carcinoma and Its Role in Drug Screening
BioMed Research International · 2023
DOI: 10.1155/2023/2501596 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioMed Research International, 2023. Verfasst von Xiaoming Gong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Hubei AIDS Clinical Training Center, Zhongnan Hospital of Wuhan University, Donghu Road 169, Wuchang District 43000…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Chinese Academy of Medical Sciences.
Abstract (Originalsprache)
Background
Vacuolar protein sorting 16 (VPS16) overexpression was recently considered related to cancer growth and drug resistance; however, little is known about whether VPS16 plays a vital role in liver hepatocellular carcinoma (LIHC).
Methods
The TIMER2 online database was used to analyze the expression of VPS16 in pancancer, and the Xena Browser was used to explore the correlation between VPS16 expression level and survival time. R language was used to test the survival data of 374 LIHC cases in the TCGA database. DESeq2 was used for differentially expressed gene (DEG) analysis. The HPA database was used to verify the expression level of VPS16 in LIHC. The clusterProfiler package was used to analyze functions and related signaling pathways via GO/KEGG enrichment analysis. Drug sensitivity analysis and molecular docking technology were used to screen the most sensitive drugs targeting VPS16 molecules.
Results
Pancancer analysis showed that VPS16 was highly expressed in various tumors, especially in LIHC. With the increase in the T stage and grade of LIHC, the expression level of VPS16 was also increased. The expression of VPS16 was negatively correlated with the overall survival of LIHC patients. The stage can be used as an independent prognostic factor. A total of 63 sensitive drugs were found, and 19 drugs were displaying strong molecular binding energy with VPS16.
Conclusion
VPS16 may be a potential biomarker for the diagnosis and prognosis of LIHC. Drugs targeting VPS16 may be used in the treatment of LIHC in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Infectious Disease, Hubei AIDS Clinical Training Center, Zhongnan Hospital of Wuhan University, Donghu Road 169, Wuchang District 430000, Wuhan, China.
- Department of Radiology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning, Hubei, China.
- Department of Radiology, Zhongnan Hospital of Wuhan University, Donghu Road 169, Wuchang District 430000, Wuhan, China.
- Cancer Research Institute, General Hospital, Ningxia Medical University, Yinchuan, China.
- Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China.
ORCID-Profile: Zhiyan Lu, Hengning Ke
Förderung
- National Natural Science Foundation of China
- Chinese Academy of Medical Sciences
Zitieren
APA
Gong, X., Chen, T., Lin, C., Ping, H., Tong, X., Zhang, K., Chen, Z., Cai, C., Lu, Z., & Ke, H. (2023). Bioinformatics Analysis of the Prognostic Significance of VPS16 in Hepatocellular Carcinoma and Its Role in Drug Screening. BioMed Research International. https://doi.org/10.1155/2023/2501596
Vancouver
Gong X, Chen T, Lin C, Ping H, Tong X, Zhang K, et al. Bioinformatics Analysis of the Prognostic Significance of VPS16 in Hepatocellular Carcinoma and Its Role in Drug Screening. BioMed Research International. 2023. doi:10.1155/2023/2501596
BibTeX
@article{Gong2023,
author = {Gong, Xiaoming and Chen, Tao and Lin, Cheyu and Ping, Haiqin and Tong, Xin and Zhang, Kai and Chen, Zhaojun and Cai, Caiyun and Lu, Zhiyan and Ke, Hengning},
title = {Bioinformatics Analysis of the Prognostic Significance of VPS16 in Hepatocellular Carcinoma and Its Role in Drug Screening},
journal = {BioMed Research International},
year = {2023},
doi = {10.1155/2023/2501596}
}
EUVIMED